SynthesisJournal of diabetes2024

Renal effects and safety between Asian and non-Asian chronic kidney disease and type 2 diabetes treated with nonsteroidal mineralocorticoid antagonists.

Xiaoming Xu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.